🇺🇸 FDA
Patent

US 8815801

Controlled release composition and method of producing the same

granted A61KA61K38/09A61K38/24

Quick answer

US patent 8815801 (Controlled release composition and method of producing the same) held by Takeda Pharmaceutical Company Limited expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/09, A61K38/24, A61K9/1617, A61K9/1647